Showing results (1051-1060 of 1,107) with videos related to

Sort By:
Pageof 111
JAMA Neurology|October 22, 2019
Interrater Reliability of Experts in Identifying Interictal Epileptiform Discharges in ElectroencephalogramsJin Jing, Aline Herlopian, Ioannis Karakis, et al.
Ebiomedicine|March 29, 2024
Acute and two-week effects of neotame, stevia rebaudioside M and sucrose-sweetened biscuits on postprandial appetite and endocrine response in adults with overweight/obesity-a randomised crossover trial from the SWEET consortiumCatherine Gibbons, Kristine Beaulieu, Eva Almiron-Roig, et al.
BMC Public Health|September 22, 2021
Diagnosis patterns of sickle cell disease in Ghana: a secondary analysisAlexandra M Sims, Kwaku Osei Bonsu, Rebekah Urbonya, et al.
Plos One|May 15, 2020
A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunctionSanjaya K Satapathy, Humberto C Gonzalez, Jason Vanatta, et al.
Geophysical Research Letters|October 17, 2022
Quantifying the Size and Duration of a Microburst-Producing Chorus Region on 5 December 2017S S Elliott, A W Breneman, C Colpitts, et al.
The Journal of Nutrition|June 9, 2020
Nondigestible Carbohydrates Affect Metabolic Health and Gut Microbiota in Overweight Adults after Weight LossAlexandra M Johnstone, Jennifer Kelly, Sheila Ryan, et al.
American Journal of Public Health|July 17, 2010
Television food advertising to children: a global perspectiveBridget Kelly, Jason C G Halford, Emma J Boyland, et al.
Nature Genetics|February 18, 2022
Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK BiobankSean J Jurgens, Seung Hoan Choi, Valerie N Morrill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2016
Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical OutcomesKaty J McCann, Ann Mander, Angelica Cazaly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2023
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced CancerSarah Halford, Gareth J Veal, Stephen R Wedge, et al.
Pageof 111